| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |